Government to increase fines up to 200 million won

Published: 2011-05-23 06:58:00

Updated: 2011-05-23 06:58:00

Starting next year, companies that were found to violate the regulation will be subject to a fine of up to 200 million from the current 50 million, according to the Korea Food and Drug Administration.

Under the revision of the Pharmaceutical Affairs Law, which was passed through the National A...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK